Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Medicine and Dentistry

• Steroid 100%
• Fusion Protein 100%
• Tumor Necrosis Factor Receptor 100%
• Allogeneic Hematopoietic Stem Cell Transplantation 100%
• Graft Versus Host Reaction 100%
• Therapeutic Procedure 100%
• Patient 100%
• Etanercept 58%
• Tumor Necrosis Factor 25%
• Combination Therapy 16%
• Inpatient 16%
• Follow up 8%
• Pathogenesis 8%
• Mediator 8%
• Mycosis 8%
• Infection 8%
• Disease Exacerbation 8%
• Alpha Adrenergic Receptor 8%
• Bacterial Infection 8%
• Chronic Graft Versus Host Disease 8%
• Acute Graft Versus Host Disease 8%
• Skin 8%
• Liver 8%
• Gut 8%